Copertina

Twelve‐Month Clinical and Cost Outcomes of Removal of Cytomegalovirus Intravenous Immune Globulin From Heart Transplantation Protocol

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Madhumita Rao, Robert L. Page, Emily Sartain
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Clinical Transplantation
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
di: Vaisak O. Nair, et al.
Pubblicazione: (2025)

Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients
di: John‐Anthony Coppola, et al.
Pubblicazione: (2025)

Effects of Nighttime Procurement and Transplantation on Outcomes Following Heart Transplantation
di: Yeahwa Hong, et al.
Pubblicazione: (2025)

Impact of the Distance Between Patient Residency and Heart Transplant Center on Outcomes After Heart Transplantation
di: Waleed Ahmad, et al.
Pubblicazione: (2024)

Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
di: Suneri J. Amin, et al.
Pubblicazione: (2025)

Impact of Age of Heart Transplant Program on Patient Survival and Post‐Transplant Outcomes
di: David T. Majure, et al.
Pubblicazione: (2024)

De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
di: Hanna L. Kleiboeker, et al.
Pubblicazione: (2025)

Long‐Term Outcomes Among Lung Transplant Recipients With High‐Risk Cytomegalovirus Mismatch Managed With a Multimodality Regimen
di: Natasha Banga, et al.
Pubblicazione: (2025)

Alternative Measures of Body Composition and Outcomes Following Heart Transplant
di: Ana Lanier, et al.
Pubblicazione: (2026)

Impact of Heart Failure Etiology on Waitlist Mortality in Heart Transplant Candidates Supported With Extracorporeal Membrane Oxygenation
di: Manuj M. Shah, et al.
Pubblicazione: (2024)

Contemporary Immunosuppression Management and 1‐Year Outcomes in Dual Organ Heart Transplantation
di: Xinyi Huang, et al.
Pubblicazione: (2024)

Decreasing the Risk of Early Sub‐Therapeutic Tacrolimus Troughs on Short‐Term Outcomes in Low‐Moderate Risk Kidney Transplant Recipients Receiving Rabbit Anti‐Thymocyte Globulin Induction
di: Xinqi Liu, et al.
Pubblicazione: (2025)

Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes
di: Masaki Tsuji, et al.
Pubblicazione: (2025)

Assessing the Role of Primary Heart Failure Etiology on Cardiac Transplant Outcomes
di: Ahad Firoz, et al.
Pubblicazione: (2024)

Risk Factors and Outcomes of Reintubation Following Combined Heart‐Lung Transplantation
di: Ye In Christopher Kwon, et al.
Pubblicazione: (2026)

Sex Differences in Incidence and Outcomes of New‐Onset Post‐Transplant Diabetes Mellitus After Heart Transplantation
di: Alice Chung, et al.
Pubblicazione: (2025)

Perioperative Timing Impacts Renal Graft Outcomes in Simultaneous Heart‐Kidney Transplantation
di: Brendan P. Lovasik, et al.
Pubblicazione: (2025)

Evolving Trends and Impact of Waitlist Transfusion on Recipient Outcomes Following Heart Transplantation
di: Yeahwa Hong, et al.
Pubblicazione: (2024)

Clinical Utility of Donor‐Derived Cell‐Free DNA in Heart Transplant Recipients With Multi‐Organ Transplants
di: Cathrine M. Moeller, et al.
Pubblicazione: (2024)

Cognitive Function Among Heart Transplant Recipients Before and After Intravenous Iron Supplement for Iron Deficiency: Results From a Randomized, Placebo‐Controlled, Double‐Blind Treatment Trial
di: Britta S. Bürker, et al.
Pubblicazione: (2025)

Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
di: Lemuel R. Non, et al.
Pubblicazione: (2024)

Heart Transplantation for Amyloid Cardiomyopathy Has Comparable Outcomes With Other Etiologies: The UNOS Database
di: Nicholas Steudel, et al.
Pubblicazione: (2025)

Outcomes of Donor‐Recipient Size Mismatch in Donation After Circulatory Death Heart Transplantation
di: Iris Feng, et al.
Pubblicazione: (2025)

Evolving Long‐Term Outcomes of Heart Transplantation Using COVID‐19 Positive Donors
di: Ye In Christopher Kwon, et al.
Pubblicazione: (2026)

Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
di: Abdallah Mughrabi, et al.
Pubblicazione: (2026)

Clinical Characteristics and Outcomes Associated With Immediate Versus Delayed Presentation of Severe Primary Graft Dysfunction After Heart Transplantation: Does Timing Matter?
di: Yosef Manla, et al.
Pubblicazione: (2025)

De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care
di: Hanna L. Kleiboeker, et al.
Pubblicazione: (2025)

Incidence and Risk Factors for Stroke After Combined Heart‐Kidney and Heart‐Liver Transplantation
di: Armaan F. Akbar, et al.
Pubblicazione: (2024)

Transition From Intraoperative Vancomycin‐Piperacillin Tazobactam to Vancomycin‐Cefepime Does Not Change Acute Kidney Injury or Renal Recovery Outcomes in Patients Undergoing Heart Transplantation
di: Ashley L. Golbus, et al.
Pubblicazione: (2025)

Risk of Post‐Transplant Malignancy After Isolated Heart Transplant Among Adult Patients With Congenital Heart Disease
di: Orly Leiva, et al.
Pubblicazione: (2025)

Risk Factors and Outcomes of Invasive Candida Infections in Heart Transplant Recipients: A Case‐Control Study
di: Majd Alsoubani, et al.
Pubblicazione: (2025)

Outcomes and Tolerability of Early Mammalian Target of Rapamycin Inhibitor Initiation for Renal Sparing in Heart Transplant Recipients
di: Avery Marcotte, et al.
Pubblicazione: (2025)

Cardio‐Renal‐Metabolic Outcomes Associated With the Use of GLP‐1 Receptor Agonists After Heart Transplantation
di: Elena M. Donald, et al.
Pubblicazione: (2024)

Time Well Spent: Clinical Predictors of Days Alive and Out of the Hospital After Heart Transplantation
di: Elissa Driggin, et al.
Pubblicazione: (2025)

Clinical Examples of the Additive Value of Absolute Quantification of Cell‐Free DNA After Heart Transplantation
di: Jens Böhmer, et al.
Pubblicazione: (2024)

The Nordic Experience of Pediatric Heart‐Lung Transplantation
di: Oscar van der Have, et al.
Pubblicazione: (2026)

Contemporary Cytomegalovirus (CMV) Infections in Low‐Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D−/R−): Time to Reexamine Donor CMV Serostatus
di: Madeleine R. Heldman, et al.
Pubblicazione: (2024)

Trends, Clinical Characteristics, and Outcomes of Percutaneous Coronary Intervention in Liver Transplant Recipients
di: Song Peng Ang, et al.
Pubblicazione: (2025)

Kidney Allograft Outcomes of Dual‐Organ Heart Kidney Transplant Recipients Following Donation After Circulatory Determination of Death
di: Ananya Gorrai, et al.
Pubblicazione: (2026)

Increasing Multiorgan Heart Transplantations From Donation After Circulatory Death Donors in the United States
di: Shivank Madan, et al.
Pubblicazione: (2024)